Giovannoni G - Search Results

1

Cladribine Tablets for Relapsing-Remitting Multiple Sclerosis: A Clinician's Review.

Giovannoni G, Mathews J. Giovannoni G, et al. Neurol Ther. 2022 Jun;11(2):571-595. doi: 10.1007/s40120-022-00339-7. Epub 2022 Mar 23. Neurol Ther. 2022. PMID: 35318617 Free PMC article. Review.

2

Serum gelatinase B/MMP-9 in primary progressive multiple sclerosis patients treated with interferon-beta-1a.

Dubois B, Leary SM, Nelissen I, Opdenakker G, Giovannoni G, Thompson AJ. Dubois B, et al. Among authors: giovannoni g. J Neurol. 2003 Sep;250(9):1037-43. doi: 10.1007/s00415-003-0110-8. J Neurol. 2003. PMID: 14504963 Clinical Trial.

3

A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis.

Giovannoni G, Comi G, Cook S, Rammohan K, Rieckmann P, Soelberg Sørensen P, Vermersch P, Chang P, Hamlett A, Musch B, Greenberg SJ; CLARITY Study Group. Giovannoni G, et al. N Engl J Med. 2010 Feb 4;362(5):416-26. doi: 10.1056/NEJMoa0902533. Epub 2010 Jan 20. N Engl J Med. 2010. PMID: 20089960 Free article. Clinical Trial.

4

Multiple sclerosis: risk factors, prodromes, and potential causal pathways.

Ramagopalan SV, Dobson R, Meier UC, Giovannoni G. Ramagopalan SV, et al. Among authors: giovannoni g. Lancet Neurol. 2010 Jul;9(7):727-39. doi: 10.1016/S1474-4422(10)70094-6. Lancet Neurol. 2010. PMID: 20610348 Review.

5

Sustained disease-activity-free status in patients with relapsing-remitting multiple sclerosis treated with cladribine tablets in the CLARITY study: a post-hoc and subgroup analysis.

Giovannoni G, Cook S, Rammohan K, Rieckmann P, Sørensen PS, Vermersch P, Hamlett A, Viglietta V, Greenberg S; CLARITY study group. Giovannoni G, et al. Lancet Neurol. 2011 Apr;10(4):329-37. doi: 10.1016/S1474-4422(11)70023-0. Lancet Neurol. 2011. PMID: 21397565

6

Autoimmune disease in people with multiple sclerosis and their relatives: a systematic review and meta-analysis.

Dobson R, Giovannoni G. Dobson R, et al. Among authors: giovannoni g. J Neurol. 2013 May;260(5):1272-85. doi: 10.1007/s00415-012-6790-1. Epub 2013 Jan 12. J Neurol. 2013. PMID: 23315260 Review.

7

Validating a novel web-based method to capture disease progression outcomes in multiple sclerosis.

Leddy S, Hadavi S, McCarren A, Giovannoni G, Dobson R. Leddy S, et al. Among authors: giovannoni g. J Neurol. 2013 Oct;260(10):2505-10. doi: 10.1007/s00415-013-7004-1. Epub 2013 Jun 27. J Neurol. 2013. PMID: 23807152

8

Lesional-targeting of neuroprotection to the inflammatory penumbra in experimental multiple sclerosis.

Al-Izki S, Pryce G, Hankey DJ, Lidster K, von Kutzleben SM, Browne L, Clutterbuck L, Posada C, Edith Chan AW, Amor S, Perkins V, Gerritsen WH, Ummenthum K, Peferoen-Baert R, van der Valk P, Montoya A, Joel SP, Garthwaite J, Giovannoni G, Selwood DL, Baker D. Al-Izki S, et al. Among authors: giovannoni g. Brain. 2014 Jan;137(Pt 1):92-108. doi: 10.1093/brain/awt324. Epub 2013 Nov 27. Brain. 2014. PMID: 24287115

9

Assessing treatment response to interferon-β: is there a role for MRI?

Dobson R, Rudick RA, Turner B, Schmierer K, Giovannoni G. Dobson R, et al. Among authors: giovannoni g. Neurology. 2014 Jan 21;82(3):248-54. doi: 10.1212/WNL.0000000000000036. Epub 2013 Dec 11. Neurology. 2014. PMID: 24336144 Free PMC article. Review.

10

Effect of daclizumab high-yield process in patients with highly active relapsing-remitting multiple sclerosis.

Giovannoni G, Radue EW, Havrdova E, Riester K, Greenberg S, Mehta L, Elkins J. Giovannoni G, et al. J Neurol. 2014 Feb;261(2):316-23. doi: 10.1007/s00415-013-7196-4. Epub 2013 Dec 29. J Neurol. 2014. PMID: 24375015 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

806 results

Search Page

Filters